ICD-9-CM procedure code (retired)
00.18 — Infusion of immunosuppressive antibody therapy
About ICD-9-CM 00.18
00.18 is an ICD-9-CM procedure code for infusion of immunosuppressive antibody therapy. ICD-9-CM was retired for U.S. claims on October 1, 2015, when ICD-10-PCS took over.
The CMS General Equivalence Mappings translate it to 70 ICD-10-PCS codes, such as 3E00X0M (Introduction of Antineoplastic, Monoclonal Antibody, into Skin and Mucous Membranes, External Approach), 3E0130M (Introduction of Antineoplastic, Monoclonal Antibody, into Subcutaneous Tissue, Percutaneous Approach) and 3E0230M (Introduction of Antineoplastic, Monoclonal Antibody, into Muscle, Percutaneous Approach). All of these are approximate matches, so review the record to pick the right one.
ICD-10-PCS equivalents
- 3E00X0MIntroduction of Antineoplastic, Monoclonal Antibody, into Skin and Mucous Membranes, External Approachapproximate
- 3E0130MIntroduction of Antineoplastic, Monoclonal Antibody, into Subcutaneous Tissue, Percutaneous Approachapproximate
- 3E0230MIntroduction of Antineoplastic, Monoclonal Antibody, into Muscle, Percutaneous Approachapproximate
- 3E0300MIntroduction of Antineoplastic, Monoclonal Antibody, into Peripheral Vein, Open Approachapproximate
- 3E030WLIntroduction of Immunosuppressive into Peripheral Vein, Openapproximate
- 3E0330MIntroduction of Antineoplastic, Monoclonal Antibody, into Peripheral Vein, Percutaneous Approachapproximate
- 3E033WLIntroduction of Immunosuppressive into Peripheral Vein, Percutaneousapproximate
- 3E0400MIntroduction of Antineoplastic, Monoclonal Antibody, into Central Vein, Open Approachapproximate
- 3E040WLIntroduction of Immunosuppressive into Central Vein, Openapproximate
- 3E0430MIntroduction of Antineoplastic, Monoclonal Antibody, into Central Vein, Percutaneous Approachapproximate
- 3E043WLIntroduction of Immunosuppressive into Central Vein, Percutaneousapproximate
- 3E0500MIntroduction of Antineoplastic, Monoclonal Antibody, into Peripheral Artery, Open Approachapproximate
- 3E050WLIntroduction of Immunosuppressive into Peripheral Artery, Openapproximate
- 3E0530MIntroduction of Antineoplastic, Monoclonal Antibody, into Peripheral Artery, Percutaneous Approachapproximate
- 3E053WLIntroduction of Immunosuppressive into Peripheral Artery, Percutaneousapproximate
- 3E0600MIntroduction of Antineoplastic, Monoclonal Antibody, into Central Artery, Open Approachapproximate
- 3E060WLIntroduction of Immunosuppressive into Central Artery, Openapproximate
- 3E0630MIntroduction of Antineoplastic, Monoclonal Antibody, into Central Artery, Percutaneous Approachapproximate
- 3E063WLIntroduction of Immunosuppressive into Central Artery, Percutaneousapproximate
- 3E0930MIntroduction of Antineoplastic, Monoclonal Antibody, into Nose, Percutaneous Approachapproximate
- 3E0970MIntroduction of Antineoplastic, Monoclonal Antibody, into Nose, Via Natural or Artificial Openingapproximate
- 3E09X0MIntroduction of Antineoplastic, Monoclonal Antibody, into Nose, External Approachapproximate
- 3E0A30MIntroduction of Antineoplastic, Monoclonal Antibody, into Bone Marrow, Percutaneous Approachapproximate
- 3E0B30MIntroduction of Antineoplastic, Monoclonal Antibody, into Ear, Percutaneous Approachapproximate
- 3E0B70MIntroduction of Antineoplastic, Monoclonal Antibody, into Ear, Via Natural or Artificial Openingapproximate
- 3E0BX0MIntroduction of Antineoplastic, Monoclonal Antibody, into Ear, External Approachapproximate
- 3E0C30MIntroduction of Antineoplastic, Monoclonal Antibody, into Eye, Percutaneous Approachapproximate
- 3E0C70MIntroduction of Antineoplastic, Monoclonal Antibody, into Eye, Via Natural or Artificial Openingapproximate
- 3E0CX0MIntroduction of Antineoplastic, Monoclonal Antibody, into Eye, External Approachapproximate
- 3E0D30MIntroduction of Antineoplastic, Monoclonal Antibody, into Mouth and Pharynx, Percutaneous Approachapproximate
- 3E0D70MIntroduction of Antineoplastic, Monoclonal Antibody, into Mouth and Pharynx, Via Natural or Artificial Openingapproximate
- 3E0DX0MIntroduction of Antineoplastic, Monoclonal Antibody, into Mouth and Pharynx, External Approachapproximate
- 3E0E30MIntroduction of Antineoplastic, Monoclonal Antibody, into Products of Conception, Percutaneous Approachapproximate
- 3E0E70MIntroduction of Antineoplastic, Monoclonal Antibody, into Products of Conception, Via Natural or Artificial Openingapproximate
- 3E0E80MIntroduction of Antineoplastic, Monoclonal Antibody, into Products of Conception, Via Natural or Artificial Opening Endoscopicapproximate
- 3E0F30MIntroduction of Antineoplastic, Monoclonal Antibody, into Respiratory Tract, Percutaneous Approachapproximate
- 3E0F70MIntroduction of Antineoplastic, Monoclonal Antibody, into Respiratory Tract, Via Natural or Artificial Openingapproximate
- 3E0F80MIntroduction of Antineoplastic, Monoclonal Antibody, into Respiratory Tract, Via Natural or Artificial Opening Endoscopicapproximate
- 3E0G30MIntroduction of Antineoplastic, Monoclonal Antibody, into Upper GI, Percutaneous Approachapproximate
- 3E0G70MIntroduction of Antineoplastic, Monoclonal Antibody, into Upper GI, Via Natural or Artificial Openingapproximate
- 3E0G80MIntroduction of Antineoplastic, Monoclonal Antibody, into Upper GI, Via Natural or Artificial Opening Endoscopicapproximate
- 3E0H30MIntroduction of Antineoplastic, Monoclonal Antibody, into Lower GI, Percutaneous Approachapproximate
- 3E0H70MIntroduction of Antineoplastic, Monoclonal Antibody, into Lower GI, Via Natural or Artificial Openingapproximate
- 3E0H80MIntroduction of Antineoplastic, Monoclonal Antibody, into Lower GI, Via Natural or Artificial Opening Endoscopicapproximate
- 3E0J30MIntroduction of Antineoplastic, Monoclonal Antibody, into Biliary and Pancreatic Tract, Percutaneous Approachapproximate
- 3E0J70MIntroduction of Antineoplastic, Monoclonal Antibody, into Biliary and Pancreatic Tract, Via Natural or Artificial Openingapproximate
- 3E0J80MIntroduction of Antineoplastic, Monoclonal Antibody, into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopicapproximate
- 3E0K30MIntroduction of Antineoplastic, Monoclonal Antibody, into Genitourinary Tract, Percutaneous Approachapproximate
- 3E0K70MIntroduction of Antineoplastic, Monoclonal Antibody, into Genitourinary Tract, Via Natural or Artificial Openingapproximate
- 3E0K80MIntroduction of Antineoplastic, Monoclonal Antibody, into Genitourinary Tract, Via Natural or Artificial Opening Endoscopicapproximate
- 3E0L30MIntroduction of Antineoplastic, Monoclonal Antibody, into Pleural Cavity, Percutaneous Approachapproximate
- 3E0L70MIntroduction of Antineoplastic, Monoclonal Antibody, into Pleural Cavity, Via Natural or Artificial Openingapproximate
- 3E0M30MIntroduction of Antineoplastic, Monoclonal Antibody, into Peritoneal Cavity, Percutaneous Approachapproximate
- 3E0M70MIntroduction of Antineoplastic, Monoclonal Antibody, into Peritoneal Cavity, Via Natural or Artificial Openingapproximate
- 3E0N30MIntroduction of Antineoplastic, Monoclonal Antibody, into Male Reproductive, Percutaneous Approachapproximate
- 3E0N70MIntroduction of Antineoplastic, Monoclonal Antibody, into Male Reproductive, Via Natural or Artificial Openingapproximate
- 3E0N80MIntroduction of Antineoplastic, Monoclonal Antibody, into Male Reproductive, Via Natural or Artificial Opening Endoscopicapproximate
- 3E0P30MIntroduction of Antineoplastic, Monoclonal Antibody, into Female Reproductive, Percutaneous Approachapproximate
- 3E0P70MIntroduction of Antineoplastic, Monoclonal Antibody, into Female Reproductive, Via Natural or Artificial Openingapproximate
- 3E0P80MIntroduction of Antineoplastic, Monoclonal Antibody, into Female Reproductive, Via Natural or Artificial Opening Endoscopicapproximate
- 3E0Q00MIntroduction of Antineoplastic, Monoclonal Antibody, into Cranial Cavity and Brain, Open Approachapproximate
- 3E0Q30MIntroduction of Antineoplastic, Monoclonal Antibody, into Cranial Cavity and Brain, Percutaneous Approachapproximate
- 3E0Q70MIntroduction of Antineoplastic, Monoclonal Antibody, into Cranial Cavity and Brain, Via Natural or Artificial Openingapproximate
- 3E0R30MIntroduction of Antineoplastic, Monoclonal Antibody, into Spinal Canal, Percutaneous Approachapproximate
- 3E0S30MIntroduction of Antineoplastic, Monoclonal Antibody, into Epidural Space, Percutaneous Approachapproximate
- 3E0U30MIntroduction of Antineoplastic, Monoclonal Antibody, into Joints, Percutaneous Approachapproximate
- 3E0V30MIntroduction of Antineoplastic, Monoclonal Antibody, into Bones, Percutaneous Approachapproximate
- 3E0W30MIntroduction of Antineoplastic, Monoclonal Antibody, into Lymphatics, Percutaneous Approachapproximate
- 3E0Y30MIntroduction of Antineoplastic, Monoclonal Antibody, into Pericardial Cavity, Percutaneous Approachapproximate
- 3E0Y70MIntroduction of Antineoplastic, Monoclonal Antibody, into Pericardial Cavity, Via Natural or Artificial Openingapproximate
Common questions about 00.18
What is the ICD-10 code for ICD-9 00.18?
- The GEMs map 00.18 to ICD-10-PCS 3E00X0M, 3E0130M, 3E0230M, 3E0300M, 3E030WL, 3E0330M and 64 more.
GEMs are a translation aid, not a substitute for coding from the record. The 2027 ICD-10 code set has changed since the last GEMs release in 2018. Page updated September 29, 2026.